Enfusion reported Q1 earnings of ($0.01) EPS, missing estimates by $0.05, and trading down $0.21 to $9.05 on Friday.
Enfusion (ENFN) reported Q1 earnings of ($0.01) EPS, missing estimates by $0.05. Revenue was $48.05M, compared to the consensus estimate of $47.67M. The company's stock traded down $0.21 to $9.05 on Friday, following the release of earnings. Enfusion has a market cap of $1.16B, a PE ratio of 112.76, a P/EG ratio of 2.79, and a beta of 0.97.
May 10, 2024
4 Articles